NEW YORK (GenomeWeb) – Focus Diagnostics today announced its Simplexa Group A Strep Direct kit has received 510(k) clearance from the US Food and Drug Administration for marketing in the US. 

The agency has also categorized the test as moderate complexity, which will allow some clinicians to perform the test directly. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.